Form 4: Lifeloc Technologies Director Exercises Stock Options
SEC Form 4 Filing
Donald E. Siecke, a director at Lifeloc Technologies, Inc., exercised stock options to acquire 1,000 shares of common stock at a price of $3.8 per share on February 28, 2025.
Summary
- On February 28, 2025, Donald E. Siecke, a director of Lifeloc Technologies, Inc., exercised stock options.
- This transaction involved the acquisition of 1,000 shares of common stock at a price of $3.8 per share.
- Following the transaction, Siecke directly owns 1,000 shares of Lifeloc Technologies, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral report of an insider transaction. It doesn't contain any information that would be considered particularly positive or negative.
Industry Context
This is a routine disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation packages. The exercise of these options is a normal part of corporate governance.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 03/01/2020 | Stock options were granted under the issuer's 2013 Stock Option Plan. |
| 02/28/2025 | Donald E. Siecke exercised stock options to acquire 1,000 shares of common stock. |
| 03/04/2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.